After mutating KRAS, APC, TP53, and SMAD4, human intestinal organoids could grow in culture without the presence of stem cell niche molecules, and the p53 stabilizer nutlin-3 allowed them to exhibit the biological characteristics observed in invasive tumor tissues in vivo (Drost et al., 2015). This evidence concerns the gene TP53 and neoplasm.